Trials
(Feb 2020)
Correction to: Efficacy of Ronopterin (VAS203) in Patients with Moderate and Severe Traumatic Brain Injury (NOSTRA phase III trial): study protocol of a confirmatory, placebocontrolled, randomised, double blind, multi-centre study
Frank Tegtmeier,
Reinhard Schinzel,
Ronny Beer,
Diederik Bulters,
Jean-Yves LeFrant,
Joan Sahuquillo,
Andreas Unterberg,
Peter Andrews,
Antonio Belli,
Javier Ibanez,
Alfonso Lagares,
Michael Mokry,
Harald Willschke,
Charlotte Flüh,
Erich Schmutzhard,
on behalf of the NOSTRA Investigators
Affiliations
Frank Tegtmeier
vasopharm GmbH
Reinhard Schinzel
vasopharm GmbH
Ronny Beer
Medizinische Universität Innsbruck
Diederik Bulters
Wessex Neurological Centre University Hospital
Jean-Yves LeFrant
Hopital Universitaire Caremeau
Joan Sahuquillo
Vall d’Hebron University Hospital
Andreas Unterberg
Universitätsklinikum Heidelberg
Peter Andrews
Western General Hospital Lothian University
Antonio Belli
Queen Elizabeth Hospital
Javier Ibanez
Espases University Hospital
Alfonso Lagares
Hospital Universitario 12 de Octubre
Michael Mokry
LKH – Universitätsklinikum Graz
Harald Willschke
Medizinische Universität Wien
Charlotte Flüh
Universitätsklinikum Schleswig-Holstein
Erich Schmutzhard
Medizinische Universität Innsbruck
on behalf of the NOSTRA Investigators
DOI
https://doi.org/10.1186/s13063-020-4107-8
Journal volume & issue
Vol. 21,
no. 1
pp.
1
– 1
Abstract
Read online
After publication of our article [1] the authors have notified us that one of the names has been incorrectly spelled.
WeChat QR code
Close